长非编码RNA RAD51-AS1通过提高EIF5A2表达率来促进卵巢癌的瘤发生
Lu Zhao1, Jia Huang2, Wenting Liu1
1Department of Obstetrics and Gynecology, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Journal of cancer research and clinical oncology
|April 7, 2024
概括
通过调节miR-140-3p/EIF5A2轴,RAD51反感RNA 1 (RAD51-AS1) 促进卵巢癌 (OvCA) 的进展. 这一发现揭示了RAD51-AS1作为OvCA患者的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 卵巢癌 (OvCA) 仍然是一个重大的健康挑战,有效治疗方法有限.
- 了解驱动OvCA进展的分子机制对于开发新型治疗策略至关重要.
研究的目的:
- 阐明RAD51反意义RNA 1 (RAD51-AS1) 影响卵巢癌 (OvCA) 的分子机制.
主要方法:
- 利用TCGA和GEO数据库的数据进行OvCA中的RAD51-AS1表达分析.
- 使用体外测试 (细胞计数,殖民地形成,伤口愈合,Transwell) 评估细胞增殖,迁移和入侵.
- 通过生物信息学,双露西法酶记者测定和体内皮下瘤发生模型研究了分子机制.
主要成果:
- 在OvCA患者中,RAD51-AS1表达与预后不佳相关.
- 过度表达RAD51-AS1增强了OvCA细胞的增殖,入侵和迁移.
- RAD51-AS1作为miR-140-3p的分子海绵,对EIF5A2的表达进行上调.
结论:
- RAD51-AS1通过miR-140-3p/EIF5A2信号轴促进OvCA的进展.
- 这个轴代表了卵巢癌治疗的潜在治疗目标.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


